When was Dexcom founded?

Dexcom was founded in 1999 and raised its 1st funding round 3 years after it was founded.

Where is Dexcom located?

Dexcom is headquartered in San Diego, United States. It is registered at 6340 Sequence Drive San Diego, CA 92121.

How many employees does Dexcom have?

As of May 31, 2026, the latest employee count at Dexcom is 8676.

Is Dexcom a funded company?

Dexcom is a funded company, having raised a total of $52.7M across 8 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Jun 03, 2002.

When was the latest funding round of Dexcom?

Dexcom's latest funding was a $***** Post IPO round on Apr 11, 2020, with participation from 0 investor. Its primary sector is Wearable Technology. In United States, the Wearable Technology sector has seen $1B in funding in 2026 to date.

What is the annual revenue of Dexcom?

Annual revenue of Dexcom is more than $1B as on Dec 31, 2025

Where does Dexcom rank among its competitors?

Dexcom ranks 1st amongst 292 active competitors, of which 76 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Signos, which secured $20M in May, 2026.

Who are the top competitors of Dexcom?

Dexcom's top competitors include Insulet, Senseonics and Signos. Among them, Signos secured the most recent funding round in May, 2026.

Dexcom - 2026 Company Profile, Team, Funding, Competitors & Financials

Dexcom is a public company based in San Diego (United States), founded in 1999 by Lauren Otsuki, Bret Megargel, Scott Glenn and Ellen Preston. It operates as a Provider of a wearable device for glucose monitoring. Dexcom has raised $52.7M in funding. The company has 292 active competitors, including 76 funded and 25 that have exited. Its top competitors include companies like Insulet, Senseonics and Signos.

Company Details

Provider of a wearable device for glucose monitoring. It provides a wearable patch that enables users to measure glucose levels in real-time. It has the capability to send data wirelessly to a display device through a transmitter and the touch screen receiver displays real-time glucose data. In 2022, the company recorded annual revenues of $3.02B and a net profit of $0.29B.

Website: www.dexcom.com/
Social
Registered Address: 6340 Sequence Drive San Diego, CA 92121

Key Metrics

Founded Year

1999

Location

San Diego, United States

Stage

Public

Total Funding

$52.7M in 8 rounds

Latest Funding Round

Post IPO, Apr 11, 2020, $*****

Investors

Invesco Mutual Fund & 8 more

Ranked

1^st among 292 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

8,676 as on May 31, 2026

Investment & Acquisitions

Oura & 6 more

Similar Companies

Insulet & 429 more

Exit Details

Public

View Dexcom's full profile

Dexcom is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DEXCOM (UK) LIMITED CIN: 9727971 , United Kingdom, Active	Aug 10, 2015	-	-
Dexcom, Inc. CIN: 3030192 , United States, Active	May 12, 1999	-	9600 (As on Dec 31, 2023)	-
DEXCOM INC CIN: 1093557 , United States, Active	May 12, 1999	$1B+ (As on Dec 31, 2025)	4562 (As on Dec 31, 2021)	-
Dexcom, Inc. CIN: 5957769 , United States, Active	Mar 08, 2021	-	-	-
DEXCOM INTERNATIONAL LTD CIN: 0756.656.022 , Belgium, Active	Oct 16, 2020	-	-	-

Dexcom got listed on Apr 14, 2005.

Click here to take a look at Dexcom's IPO in detail

Dexcom has raised a total funding of $52.7M over 8 rounds. Its first funding round was on Jun 03, 2002. Dexcom has 9 institutional investors.

Here is the list of recent funding rounds of Dexcom:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 11, 2020	8595032	Post IPO	5069596	6292280	2131714	4593992
Dec 03, 2018	7183733	Post IPO	6560516	2251072	4521273	4864688
May 02, 2016	3477874	Post IPO	1305742	7183572	6898674	6740136

Access funding benchmarks and valuations. Sign up today!

View details of Dexcom's funding rounds and investors

The founders of Dexcom are Lauren Otsuki, Bret Megargel, Scott Glenn and Ellen Preston. Kevin Sayer is the CEO of Dexcom.

Here are the details of Dexcom's key team members:

Lauren Otsuki: Former Co-Founder of Dexcom and founder of 1 other company. They serve on the board of 1 company.
Bret Megargel: Co-Founder of Dexcom and founder of 1 other company.
Scott Glenn: Former Co-Founder & Chairman of Dexcom.
Ellen Preston: Former Co-Founder of Dexcom.

View details of Dexcom's Founder profiles and Board Members

Dexcom's employee count trend

Dexcom has 8,676 employees as of May 26. Here is Dexcom's employee count trend over the years:

Uncover Dexcom's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dexcom include Insulet, Senseonics and Signos. Here is the list of Top 10 competitors of Dexcom, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dexcom 1999, San Diego (United States), Public	Provider of a wearable device for glucose monitoring	$52.7M	Invesco Mutual Fund, Lucas Venture Group & 7 others	79/100
2nd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	77/100
3rd	Senseonics 1996, Germantown (United States), Public	Provider of implantable systems for continuous glucose monitoring	$165M	Greenspring Associates, BioStar Capital & 9 others	71/100
4th	Signos 2020, San Francisco (United States), Series B	Provider of a wearable device for blood glucose pattern monitoring	$57M	Google Ventures, Cheyenne Ventures & 14 others	71/100
5th	Livongo 2014, San Francisco (United States), Acquired	Provider of smart devices for diabetes management for patients and doctors	$245M	General Catalyst, Kinnevik & 21 others	70/100
6th	mySugr 2012, Vienna (Austria), Acquired	Gamification apps for diabetes management and therapy	$4.8M	iSeed Ventures, Roche & 7 others	70/100
7th	sugar.fit 2021, Bengaluru (India), Series A	Provider of diabetes care and reversal programs	$26.7M	B Capital, MassMutual Ventures & 16 others	68/100
8th	One Drop 2015, New York City (United States), Series C	Provider of workforce healthcare solutions	$108M	RRE Ventures, Bayer & 16 others	65/100
9th	Jana Care 2011, Newton (United States), Series C	Provider of mobile-based healthcare diagnostics for diabetes prevention	$35.7M	IAG Capital Partners, MK Energy & 16 others	63/100
10th	Liom 2017, Pfaffikon (Switzerland), Series A	Platform offering non invasive glucose monitoring solutions	$79.3M	Ornament, Daniel Gutenberg & 11 others	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Dexcom's competitors? Click here to see the top ones

Dexcom has made 5 investments in companies including Oura and Oura. Dexcom has also acquired 2 companies including TypeZero Technologies and SweetSpot Diabetes.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Dec 19, 2024	Investments	Oura	2013	Oulu (Finland)
Nov 19, 2024	Investments	Oura	2013	Oulu (Finland)
Apr 15, 2024	Investments	Phenomix Sciences	2017	Saint Paul (United States)